Metraipolis › archive › dc_eb6f2d55983e
Sodium-Glucose Cotransporter-2 Inhibitors in Diabetes and Beyond: Mechanisms, Pleiotropic Benefits, and Clinical Use-Reviewing Protective Effects Exceeding… — Europe PMC PMID:41157142
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41157142
- DOI
- 10.3390/molecules30204125
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T05:20:19.648Z
- SHA-256 of the archived text
e676ae8323576391ebcce10b4f0cff102a9f6f6d636ec5b6504513d8b3d74c74- Stable URL of this page
https://metraipolis.com/documento/dc_eb6f2d55983e
How to cite
Sodium-Glucose Cotransporter-2 Inhibitors in Diabetes and Beyond: Mechanisms, Pleiotropic Benefits, and Clinical Use-Reviewing Protective Effects Exceeding… — Europe PMC PMID:41157142 — Europe PMC (en), https://europepmc.org/article/MED/41157142 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eb6f2d55983e (Metraipolis archive dc_eb6f2d55983e, sha256 e676ae8323576391ebcce10b4f0cff102a9f6f6d636ec5b6504513d8b3d74c74)
BibTeX
@misc{dceb6f2d55983e,
title = {Sodium-Glucose Cotransporter-2 Inhibitors in Diabetes and Beyond: Mechanisms, Pleiotropic Benefits, and Clinical Use-Reviewing Protective Effects Exceeding… — Europe PMC PMID:41157142},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41157142},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eb6f2d55983e; sha256 e676ae8323576391ebcce10b4f0cff102a9f6f6d636ec5b6504513d8b3d74c74},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41157142. Agents can read the archived copy with the MCP tool read_document.